1: Fiorentino J, Payne M, Cancian E, Plonka A, Dumas LÉ, Chirio D, Demonchy É,
Risso K, Askenazy-Gittard F, Guevara N, Castillo L, Robert P, Manera V,
Vandersteen C, Gros A. Correlations between Persistent Olfactory and Semantic
Memory Disorders after SARS-CoV-2 Infection. Brain Sci. 2022 May 31;12(6):714.
doi: 10.3390/brainsci12060714. PMID: 35741601; PMCID: PMC9221020.

2: Chen M, Zhu Y, Li H, Zhang Y, Han M. A Quantitative Proteomic Approach
Explores the Possible Mechanisms by Which the Small Molecule Stemazole Promotes
the Survival of Human Neural Stem Cells. Brain Sci. 2022 May 25;12(6):690. doi:
10.3390/brainsci12060690. PMID: 35741576; PMCID: PMC9221083.

3: Galizzi G, Di Carlo M. Insulin and Its Key Role for Mitochondrial
Function/Dysfunction and Quality Control: A Shared Link between Dysmetabolism
and Neurodegeneration. Biology (Basel). 2022 Jun 20;11(6):943. doi:
10.3390/biology11060943. PMID: 35741464; PMCID: PMC9220302.

4: Chithanathan K, Xuan FL, Hickey MA, Tian L. Enhanced Anxiety and Olfactory
Microglial Activation in Early-Stage Familial Alzheimer's Disease Mouse Model.
Biology (Basel). 2022 Jun 20;11(6):938. doi: 10.3390/biology11060938. PMID:
35741458; PMCID: PMC9219751.

5: Chung SE, Kim HJ, Jo S, Lee S, Lee Y, Roh JH, Lee JH. Patterns of Focal
Amyloid Deposition Using <sup>18</sup>F-Florbetaben PET in Patients with
Cognitive Impairment. Diagnostics (Basel). 2022 May 31;12(6):1357. doi:
10.3390/diagnostics12061357. PMID: 35741166; PMCID: PMC9221882.

6: Callens M, Loncke J, Bultynck G. Dysregulated Ca<sup>2+</sup> Homeostasis as
a Central Theme in Neurodegeneration: Lessons from Alzheimer's Disease and
Wolfram Syndrome. Cells. 2022 Jun 18;11(12):1963. doi: 10.3390/cells11121963.
PMID: 35741091; PMCID: PMC9221778.

7: Salemi M, Mogavero MP, Lanza G, Mongioì LM, Calogero AE, Ferri R. Examples of
Inverse Comorbidity between Cancer and Neurodegenerative Diseases: A Possible
Role for Noncoding RNA. Cells. 2022 Jun 15;11(12):1930. doi:
10.3390/cells11121930. PMID: 35741059; PMCID: PMC9221903.

8: Li T, Lu L, Pember E, Li X, Zhang B, Zhu Z. New Insights into
Neuroinflammation Involved in Pathogenic Mechanism of Alzheimer's Disease and
Its Potential for Therapeutic Intervention. Cells. 2022 Jun 14;11(12):1925. doi:
10.3390/cells11121925. PMID: 35741054; PMCID: PMC9221885.

9: Rajesh Y, Kanneganti TD. Innate Immune Cell Death in Neuroinflammation and
Alzheimer's Disease. Cells. 2022 Jun 10;11(12):1885. doi: 10.3390/cells11121885.
PMID: 35741014; PMCID: PMC9221514.

10: Blount GS, Coursey L, Kocerha J. MicroRNA Networks in Cognition and
Dementia. Cells. 2022 Jun 9;11(12):1882. doi: 10.3390/cells11121882. PMID:
35741010; PMCID: PMC9221254.

11: Wefers Z, Alecki C, Huang R, Jacob-Tomas S, Vera M. Analysis of the
Expression and Subcellular Distribution of <i>eEF1A1</i> and <i>eEF1A2</i> mRNAs
during Neurodevelopment. Cells. 2022 Jun 9;11(12):1877. doi:
10.3390/cells11121877. PMID: 35741005; PMCID: PMC9220863.

12: Espinoza S, Grunenwald F, Gomez W, García F, Abarzúa-Catalan L, Oyarce-Pezoa
S, Hernandez MF, Cortés BI, Uhrig M, Ponce DP, Durán-Aniotz C, Hetz C, SanMartín
CD, Cornejo VH, Ezquer F, Parra V, Behrens MI, Manque PA, Rojas-Rivera D, Vidal
RL, Woehlbier U, Nassif M. Neuronal Rubicon Represses Extracellular APP/Amyloid
β Deposition in Alzheimer's Disease. Cells. 2022 Jun 7;11(12):1860. doi:
10.3390/cells11121860. PMID: 35740989; PMCID: PMC9221152.

13: Murtas G, Pollegioni L, Molla G, Sacchi S. Biochemical Properties and
Physiological Functions of pLG72: Twenty Years of Investigations. Biomolecules.
2022 Jun 20;12(6):858. doi: 10.3390/biom12060858. PMID: 35740983; PMCID:
PMC9220908.

14: Zhang HL, Wang XC, Liu R. Zinc in Regulating Protein Kinases and
Phosphatases in Neurodegenerative Diseases. Biomolecules. 2022 Jun 4;12(6):785.
doi: 10.3390/biom12060785. PMID: 35740910; PMCID: PMC9220840.

15: Moreau M, Carmona-Iragui M, Altuna M, Dalzon L, Barroeta I, Vilaire M,
Durand S, Fortea J, Rebillat AS, Janel N. DYRK1A and Activity-Dependent
Neuroprotective Protein Comparative Diagnosis Interest in Cerebrospinal Fluid
and Plasma in the Context of Alzheimer-Related Cognitive Impairment in Down
Syndrome Patients. Biomedicines. 2022 Jun 10;10(6):1380. doi:
10.3390/biomedicines10061380. PMID: 35740400; PMCID: PMC9219646.

16: Lee DH, Lee JY, Hong DY, Lee EC, Park SW, Jo YN, Park YJ, Cho JY, Cho YJ,
Chae SH, Lee MR, Oh JS. ROCK and PDE-5 Inhibitors for the Treatment of Dementia:
Literature Review and Meta-Analysis. Biomedicines. 2022 Jun 8;10(6):1348. doi:
10.3390/biomedicines10061348. PMID: 35740369; PMCID: PMC9219677.

17: Rubio-Casillas A, Redwan EM, Uversky VN. SARS-CoV-2: A Master of Immune
Evasion. Biomedicines. 2022 Jun 7;10(6):1339. doi: 10.3390/biomedicines10061339.
PMID: 35740361; PMCID: PMC9220273.

18: Cherbuin N, Walsh EI, Leach L, Brüstle A, Burns R, Anstey KJ, Sachdev PS,
Baune BT. Systemic Inflammation Predicts Alzheimer Pathology in Community
Samples without Dementia. Biomedicines. 2022 May 26;10(6):1240. doi:
10.3390/biomedicines10061240. PMID: 35740262; PMCID: PMC9219863.

19: Facchinetti R, Valenza M, Gomiero C, Mancini GF, Steardo L, Campolongo P,
Scuderi C. Co-Ultramicronized Palmitoylethanolamide/Luteolin Restores
Oligodendrocyte Homeostasis via Peroxisome Proliferator-Activated Receptor-α in
an In Vitro Model of Alzheimer's Disease. Biomedicines. 2022 May 26;10(6):1236.
doi: 10.3390/biomedicines10061236. PMID: 35740258; PMCID: PMC9219769.

20: Bruno F, Malvaso A, Canterini S, Bruni AC. Antimicrobial Peptides (AMPs) in
the Pathogenesis of Alzheimer's Disease: Implications for Diagnosis and
Treatment. Antibiotics (Basel). 2022 May 28;11(6):726. doi:
10.3390/antibiotics11060726. PMID: 35740133; PMCID: PMC9220182.

21: Lazzarino G, Amorini AM, Mangione R, Saab MW, Di Stasio E, Di Rosa M,
Tavazzi B, Lazzarino G, Onder G, Carfì A. Biochemical Discrimination of the Down
Syndrome-Related Metabolic and Oxidative/Nitrosative Stress Alterations from the
Physiologic Age-Related Changes through the Targeted Metabolomic Analysis of
Serum. Antioxidants (Basel). 2022 Jun 20;11(6):1208. doi:
10.3390/antiox11061208. PMID: 35740106; PMCID: PMC9219806.

22: Iorio R, Celenza G, Petricca S. Multi-Target Effects of ß-Caryophyllene and
Carnosic Acid at the Crossroads of Mitochondrial Dysfunction and
Neurodegeneration: From Oxidative Stress to Microglia-Mediated
Neuroinflammation. Antioxidants (Basel). 2022 Jun 18;11(6):1199. doi:
10.3390/antiox11061199. PMID: 35740096; PMCID: PMC9220155.

23: Alvarez-Mora MI, Garrabou G, Barcos T, Garcia-Garcia F, Grillo-Risco R,
Peruga E, Gort L, Borrego-Écija S, Sanchez-Valle R, Canto-Santos J, Navarro-
Navarro P, Rodriguez-Revenga L. Bioenergetic and Autophagic Characterization of
Skin Fibroblasts from <i>C9orf72</i> Patients. Antioxidants (Basel). 2022 Jun
8;11(6):1129. doi: 10.3390/antiox11061129. PMID: 35740026; PMCID: PMC9219955.

24: Raza A, Xie W, Kim KH, Dronamraju VR, Williams J, Vince R, More SS.
Dipeptide of ψ-GSH Inhibits Oxidative Stress and Neuroinflammation in an
Alzheimer's Disease Mouse Model. Antioxidants (Basel). 2022 May 28;11(6):1075.
doi: 10.3390/antiox11061075. PMID: 35739972; PMCID: PMC9219802.

25: Liu S, Liu C, Wang XD, Lu H, Ji Y. Cognitive profile in mild cognitive
impairment with Lewy bodies. Singapore Med J. 2022 Jun 24. doi:
10.11622/smedj.2022085. Epub ahead of print. PMID: 35739625.

26: Yamashita K, Miura M, Watanabe S, Ishiki K, Arimatsu Y, Kawahira J, Kubo T,
Sasaki K, Arai T, Hagino K, Irino Y, Nagai K, Verbel D, Koyama A, Dhadda S,
Niiro H, Iwanaga S, Sato T, Yoshida T, Iwata A. Fully automated and highly
specific plasma β-amyloid immunoassays predict β-amyloid status defined by
amyloid positron emission tomography with high accuracy. Alzheimers Res Ther.
2022 Jun 23;14(1):86. doi: 10.1186/s13195-022-01029-0. PMID: 35739591; PMCID:
PMC9219197.

27: Tok S, Maurin H, Delay C, Crauwels D, Manyakov NV, Van Der Elst W, Moechars
D, Drinkenburg WHIM. Pathological and neurophysiological outcomes of seeding
human-derived tau pathology in the APP-KI NL-G-F and NL-NL mouse models of
Alzheimer's Disease. Acta Neuropathol Commun. 2022 Jun 23;10(1):92. doi:
10.1186/s40478-022-01393-w. PMID: 35739575; PMCID: PMC9219251.

28: Guo M, Jia J, Zhang J, Zhou M, Wang A, Chen S, Zhao X. Association of β-cell
function and cognitive impairment in patients with abnormal glucose metabolism.
BMC Neurol. 2022 Jun 23;22(1):232. doi: 10.1186/s12883-022-02755-6. PMID:
35739484; PMCID: PMC9219116.

29: Cao SQ, Aman Y, Fang EF, Tencomnao T. P. edulis Extract Protects Against
Amyloid-β Toxicity in Alzheimer's Disease Models Through Maintenance of
Mitochondrial Homeostasis via the FOXO3/DAF-16 Pathway. Mol Neurobiol. 2022
Sep;59(9):5612-5629. doi: 10.1007/s12035-022-02904-5. Epub 2022 Jun 23. PMID:
35739408.

30: Bellmund JLS, Deuker L, Montijn ND, Doeller CF. Mnemonic construction and
representation of temporal structure in the hippocampal formation. Nat Commun.
2022 Jun 23;13(1):3395. doi: 10.1038/s41467-022-30984-3. PMID: 35739096; PMCID:
PMC9226117.

31: Costa A, Pais M, Loureiro J, Stella F, Radanovic M, Gattaz W, Forlenza O,
Talib L. Decision tree-based classification as a support to diagnosis in the
Alzheimer's disease continuum using cerebrospinal fluid biomarkers: insights
from automated analysis. Braz J Psychiatry. 2022 Aug 30;44(4):370-377. doi:
10.47626/1516-4446-2021-2277. PMID: 35739065; PMCID: PMC9375672.

32: Maeker É, Roche J, Maeker-Poquet B. Annonce du diagnostic de maladie
d’Alzheimer ou apparentée en service de court séjour gériatrique [Announcement
of the diagnosis of Alzheimer's disease or a related disorder in a geriatric
short-stay unit]. Soins Gerontol. 2022 May-Jun;27(155):33-37. French. doi:
10.1016/j.sger.2022.03.009. Epub 2022 Jun 3. PMID: 35738763.

33: Delbreil P, Rabanel JM, Banquy X, Brambilla D. Therapeutic nanotechnologies
for Alzheimer's disease: A critical analysis of recent trends and findings. Adv
Drug Deliv Rev. 2022 Aug;187:114397. doi: 10.1016/j.addr.2022.114397. Epub 2022
Jun 20. PMID: 35738546.

34: Williams ME, Gillespie NA, Bell TR, Dale AM, Elman JA, Eyler LT, Fennema-
Notestine C, Franz CE, Hagler DJ Jr, Lyons MJ, McEvoy LK, Neale MC, Panizzon MS,
Reynolds CA, Sanderson-Cimino M, Kremen WS. Genetic and environmental influences
on structural- and diffusion-based Alzheimer's disease neuroimaging signatures
across midlife and early old age. Biol Psychiatry Cogn Neurosci Neuroimaging.
2022 Jun 20:S2451-9022(22)00151-3. doi: 10.1016/j.bpsc.2022.06.007. Epub ahead
of print. PMID: 35738479.

35: Rong Y, Mi X, Ni C, Liu T, Yang N, Hong J, Li Y, Li Z, Han D, Guo X.
Protective effect of vitamin C on DNA damage in surgery-induced cognitive
dysfunction in APP/PS1 mice. Neurosci Lett. 2022 Jul 27;784:136740. doi:
10.1016/j.neulet.2022.136740. Epub 2022 Jun 21. PMID: 35738457.

36: Ju YH, Bhalla M, Hyeon SJ, Oh JE, Yoo S, Chae U, Kwon J, Koh W, Lim J, Park
YM, Lee J, Cho IJ, Lee H, Ryu H, Lee CJ. Astrocytic urea cycle detoxifies Aβ-
derived ammonia while impairing memory in Alzheimer's disease. Cell Metab. 2022
Aug 2;34(8):1104-1120.e8. doi: 10.1016/j.cmet.2022.05.011. Epub 2022 Jun 22.
PMID: 35738259.

37: Mohammadi S, Rafii-Tabar H, Sasanpour P. A modeling study of the effect of
an alternating magnetic field on magnetite nanoparticles in proximity of the
neuronal microtubules: A proposed mechanism for detachment of tau proteins.
Comput Methods Programs Biomed. 2022 Jul;222:106913. doi:
10.1016/j.cmpb.2022.106913. Epub 2022 May 25. PMID: 35738092.

38: Teh SK, Rawtaer I, Tan HP. Predictive Accuracy of Digital Biomarker
Technologies for Detection of Mild Cognitive Impairment and Pre-Frailty Amongst
Older Adults: A Systematic Review and Meta-Analysis. IEEE J Biomed Health
Inform. 2022 Aug;26(8):3638-3648. doi: 10.1109/JBHI.2022.3185798. Epub 2022 Aug
11. PMID: 35737623.

39: Wright LM, De Marco M, Venneri A. Verbal fluency discrepancies as a marker
of the prehippocampal stages of Alzheimer's disease. Neuropsychology. 2022 Jun
23. doi: 10.1037/neu0000836. Epub ahead of print. PMID: 35737533.

40: Leder G, Derse AR. Alzheimer's Disease and the Invisible Person: The Missing
Patient Voice. Am J Bioeth. 2022 Jul;22(7):87-90. doi:
10.1080/15265161.2022.2075964. PMID: 35737481.

41: Mei J, Yang H, Ahmad S, Ma X, Xu W, Gao W, Li Y, Wang C, Ai H. Toxicity
Mechanism of Aβ42 Oligomer in the Binding between the GABA<sub>B</sub>R1a sushi1
Domain and Amyloid Precursor Protein 9mer: A Mechanism like Substitution
Reaction. ACS Chem Neurosci. 2022 Jul 6;13(13):2048-2059. doi:
10.1021/acschemneuro.2c00311. Epub 2022 Jun 23. PMID: 35737468.

42: Duchowny KA, Ackley SF, Brenowitz WD, Wang J, Zimmerman SC, Caunca MR,
Glymour MM. Associations Between Handgrip Strength and Dementia Risk, Cognition,
and Neuroimaging Outcomes in the UK Biobank Cohort Study. JAMA Netw Open. 2022
Jun 1;5(6):e2218314. doi: 10.1001/jamanetworkopen.2022.18314. PMID: 35737388;
PMCID: PMC9227006.

43: Peretti DE, Vállez García D, Renken RJ, Reesink FE, Doorduin J, de Jong BM,
De Deyn PP, Dierckx RAJO, Boellaard R. Alzheimer's disease pattern derived from
relative cerebral flow as an alternative for the metabolic pattern using
SSM/PCA. EJNMMI Res. 2022 Jun 23;12(1):37. doi: 10.1186/s13550-022-00909-8.
PMID: 35737201; PMCID: PMC9226207.

44: Barschke P, Abu-Rumeileh S, Al Shweiki MHDR, Barba L, Paolini Paoletti F,
Oeckl P, Steinacker P, Halbgebauer S, Gaetani L, Lewerenz J, Ludolph AC,
Landwehrmeyer GB, Parnetti L, Otto M. Cerebrospinal fluid levels of
proenkephalin and prodynorphin are differentially altered in Huntington's and
Parkinson's disease. J Neurol. 2022 Sep;269(9):5136-5143. doi:
10.1007/s00415-022-11187-8. Epub 2022 Jun 23. PMID: 35737109; PMCID: PMC9363351.

45: Rizevsky S, Zhaliazka K, Matveyenka M, Quinn K, Kurouski D. Lipids reverse
supramolecular chirality and reduce toxicity of amyloid fibrils. FEBS J. 2022
Jun 23. doi: 10.1111/febs.16564. Epub ahead of print. PMID: 35736671.

46: Areche C, Parra JR, Sepulveda B, García-Beltrán O, Simirgiotis MJ. UHPLC-MS
Metabolomic Fingerprinting, Antioxidant, and Enzyme Inhibition Activities of
<i>Himantormia lugubris</i> from Antarctica. Metabolites. 2022 Jun 18;12(6):560.
doi: 10.3390/metabo12060560. PMID: 35736493; PMCID: PMC9227586.

47: Kelley AR. Mass Spectrometry-Based Analysis of Lipid Involvement in
Alzheimer's Disease Pathology-A Review. Metabolites. 2022 Jun 2;12(6):510. doi:
10.3390/metabo12060510. PMID: 35736443; PMCID: PMC9228715.

48: Miyan J, Buttercase C, Beswick E, Miyan S, Moshkdanian G, Naz N. Folate
Related Pathway Gene Analysis Reveals a Novel Metabolic Variant Associated with
Alzheimer's Disease with a Change in Metabolic Profile. Metabolites. 2022 May
24;12(6):475. doi: 10.3390/metabo12060475. PMID: 35736408; PMCID: PMC9230919.

49: Martins B, Vieira M, Delerue-Matos C, Grosso C, Soares C. Biological
Potential, Gastrointestinal Digestion, Absorption, and Bioavailability of Algae-
Derived Compounds with Neuroprotective Activity: A Comprehensive Review. Mar
Drugs. 2022 May 28;20(6):362. doi: 10.3390/md20060362. PMID: 35736165; PMCID:
PMC9227170.

50: Chiang HS, Khera A, Stopschinski BE, Stuve O, Hart J Jr, Kelley B, Nguyen T.
Cognitive Decline in Older People with Multiple Sclerosis-A Narrative Review of
the Literature. Geriatrics (Basel). 2022 Jun 5;7(3):61. doi:
10.3390/geriatrics7030061. PMID: 35735766; PMCID: PMC9223056.

51: Chang BK, Day GS, Graff-Radford J, McKeon A, Flanagan EP, Algeciras-
Schimnich A, Mielke MM, Nguyen A, Jones DT, Toledano M, Kremers WK, Knopman DS,
Petersen RC, Li W. Alzheimer's disease cerebrospinal fluid biomarkers
differentiate patients with Creutzfeldt-Jakob disease and autoimmune
encephalitis. Eur J Neurol. 2022 Oct;29(10):2905-2912. doi: 10.1111/ene.15469.
Epub 2022 Jul 5. PMID: 35735602; PMCID: PMC9463096.

52: Guo R, Hu J, Jing J, Liu Y, Li J, Zhou Y, Liu H, Zhou L, Chen X. LC-MS/MS
assay of fluoropezil and its two major metabolites in human plasma: an
application to pharmacokinetic studies. Bioanalysis. 2022 Jun;14(11):817-829.
doi: 10.4155/bio-2022-0045. Epub 2022 Jun 23. PMID: 35735138.

53: Chen T, Yuan M, Tang J, Lu L. Digital Analysis of Smart Registration Methods
for Magnetic Resonance Images in Public Healthcare. Front Public Health. 2022
Jun 6;10:896967. doi: 10.3389/fpubh.2022.896967. PMID: 35734757; PMCID:
PMC9207932.

54: Antal A, Luber B, Brem AK, Bikson M, Brunoni AR, Cohen Kadosh R, Dubljević
V, Fecteau S, Ferreri F, Flöel A, Hallett M, Hamilton RH, Herrmann CS, Lavidor
M, Loo C, Lustenberger C, Machado S, Miniussi C, Moliadze V, Nitsche MA, Rossi
S, Rossini PM, Santarnecchi E, Seeck M, Thut G, Turi Z, Ugawa Y,
Venkatasubramanian G, Wenderoth N, Wexler A, Ziemann U, Paulus W. Non-invasive
brain stimulation and neuroenhancement. Clin Neurophysiol Pract. 2022 May
25;7:146-165. doi: 10.1016/j.cnp.2022.05.002. PMID: 35734582; PMCID: PMC9207555.

55: Zhou DA, Xu K, Zhao X, Chen Q, Sang F, Fan D, Su L, Zhang Z, Ai L, Chen Y.
Spatial Distribution and Hierarchical Clustering of β-Amyloid and Glucose
Metabolism in Alzheimer's Disease. Front Aging Neurosci. 2022 Jun 6;14:788567.
doi: 10.3389/fnagi.2022.788567. PMID: 35734543; PMCID: PMC9207533.

56: Carlyle BC, Kitchen RR, Mattingly Z, Celia AM, Trombetta BA, Das S, Hyman
BT, Kivisäkk P, Arnold SE. Technical Performance Evaluation of Olink Proximity
Extension Assay for Blood-Based Biomarker Discovery in Longitudinal Studies of
Alzheimer's Disease. Front Neurol. 2022 Jun 6;13:889647. doi:
10.3389/fneur.2022.889647. PMID: 35734478; PMCID: PMC9207419.

57: Kim NG, Effken JA. Disturbance of Ecological Self and Impairment of
Affordance Perception. Front Psychol. 2022 Jun 6;13:925359. doi:
10.3389/fpsyg.2022.925359. PMID: 35734450; PMCID: PMC9207710.

58: Zazzara MB, Vetrano DL, Carfì A, Liperoti R, Damiano C, Onder G. Comorbidity
patterns in institutionalized older adults affected by dementia. Alzheimers
Dement (Amst). 2022 Jun 14;14(1):e12320. doi: 10.1002/dad2.12320. PMID:
35734097; PMCID: PMC9197250.

59: Coerver K, Yu MM, D'Abreu A, Wasserman M, Nair KV. Practical Considerations
in the Administration of Aducanumab for the Neurologist. Neurol Clin Pract. 2022
Apr;12(2):169-175. doi: 10.1212/CPJ.0000000000001144. PMID: 35733944; PMCID:
PMC9208401.

60: Liu G, Zhang X, Huo X, Li W. Prevalence, Influencing Factors, and Clinical
Characteristics of Cognitive Impairment in Elderly Patients With Schizophrenia.
Front Psychiatry. 2022 Jun 6;13:910814. doi: 10.3389/fpsyt.2022.910814. PMID:
35733805; PMCID: PMC9207234.

61: Gaur A, Kaliappan A, Balan Y, Sakthivadivel V, Medala K, Umesh M. Sleep and
Alzheimer: The Link. Maedica (Bucur). 2022 Mar;17(1):177-185. doi:
10.26574/maedica.2022.17.1.177. PMID: 35733758; PMCID: PMC9168575.

62: Daly T. Are trailblazing trials for reducing cognitive decline putting the
cart before the horse? Alzheimers Dement (N Y). 2022 Jun 13;8(1):e12298. doi:
10.1002/trc2.12298. PMID: 35733646; PMCID: PMC9191824.

63: Roach JC, Hodes JF, Funk CC, Shankle WR, Merrill DA, Hood L, Bramen J. Dense
data enables 21st century clinical trials. Alzheimers Dement (N Y). 2022 Jun
13;8(1):e12297. doi: 10.1002/trc2.12297. Erratum in: Alzheimers Dement (N Y).
2022 Jul 25;8(1):e12336. PMID: 35733645; PMCID: PMC9191823.

64: Hung L, Mann J, Perry J, Berndt A, Wong J. Technological risks and ethical
implications of using robots in long-term care. J Rehabil Assist Technol Eng.
2022 Jun 17;9:20556683221106917. doi: 10.1177/20556683221106917. PMID: 35733613;
PMCID: PMC9208036.

65: Das S, Puthankattil SD. Functional Connectivity and Complexity in the
Phenomenological Model of Mild Cognitive-Impaired Alzheimer's Disease. Front
Comput Neurosci. 2022 Jun 6;16:877912. doi: 10.3389/fncom.2022.877912. PMID:
35733555; PMCID: PMC9207343.

66: Scheijbeler EP, van Nifterick AM, Stam CJ, Hillebrand A, Gouw AA, de Haan W.
Network-level permutation entropy of resting-state MEG recordings: A novel
biomarker for early-stage Alzheimer's disease? Netw Neurosci. 2022 Jun
1;6(2):382-400. doi: 10.1162/netn_a_00224. PMID: 35733433; PMCID: PMC9208018.

67: Simanaviciute U, Brown RE, Wong A, Fertan E, Grant RA. Abnormal whisker
movements in the 3xTg-AD mouse model of Alzheimer's disease. Genes Brain Behav.
2022 Jun 22:e12813. doi: 10.1111/gbb.12813. Epub ahead of print. PMID: 35733405.

68: Agarwal K, Katare DP, Jakhmola-Mani R. Foresee novel targets for Alzheimer's
disease by investigating repurposed drugs. CNS Neurol Disord Drug Targets. 2022
Jun 22. doi: 10.2174/1871527321666220622162622. Epub ahead of print. PMID:
35733313.

69: Goyal A, Gopika S, Agrawal N. Basic Leucine Zipper Protein Nuclear factor
erythroid 2-related factor 2 as a Potential Therapeutic Target in Brain Related
Disorders. Protein Pept Lett. 2022 Jun 22. doi:
10.2174/0929866529666220622124253. Epub ahead of print. PMID: 35733308.

70: Neri I, Boschetti E, Follo MY, De Giorgio R, Cocco L, Manzoli L, Ratti S.
Microbiota-Gut-Brain Axis in Neurological Disorders: From Leaky Barriers
Microanatomical Changes to Biochemical Processes. Mini Rev Med Chem. 2022 Jun
22. doi: 10.2174/1389557522666220622111501. Epub ahead of print. PMID: 35733303.

71: Clark LR, Erickson CM, Jonaitis EM, Ma Y, Chin NA, Basche K, Ketchum FB,
Gleason CE. Anticipated reactions to learning Alzheimer's disease biomarker
results. Alzheimers Res Ther. 2022 Jun 22;14(1):85. doi:
10.1186/s13195-022-01027-2. PMID: 35733219; PMCID: PMC9214979.

72: Dromard Y, Arango-Lievano M, Borie A, Dedin M, Fontanaud P, Torrent J,
Garabedian MJ, Ginsberg SD, Jeanneteau F. Loss of glucocorticoid receptor
phosphorylation contributes to cognitive and neurocentric damages of the
amyloid-β pathway. Acta Neuropathol Commun. 2022 Jun 22;10(1):91. doi:
10.1186/s40478-022-01396-7. PMID: 35733193; PMCID: PMC9219215.

73: Sadarangani T, Perissinotto C, Boafo J, Zhong J, Yu G. Multimorbidity
patterns in adult day health center clients with dementia: a latent class
analysis. BMC Geriatr. 2022 Jun 22;22(1):514. doi: 10.1186/s12877-022-03206-0.
PMID: 35733122; PMCID: PMC9216285.

74: Lin XY, Huang YW, Fan YW, Chen YT, Pathak N, Hsu YC, Yang JM. Identification
of pan-kinase-family inhibitors using graph convolutional networks to reveal
family-sensitive pre-moieties. BMC Bioinformatics. 2022 Jun 22;23(Suppl 4):247.
doi: 10.1186/s12859-022-04773-0. PMID: 35733108; PMCID: PMC9214975.

75: Spampinato SF, Takeshita Y, Obermeier B. An In Vitro Model of the Blood-
Brain Barrier to Study Alzheimer's Disease: The Role of β-Amyloid and Its
Influence on PBMC Infiltration. Methods Mol Biol. 2022;2492:333-352. doi:
10.1007/978-1-0716-2289-6_20. PMID: 35733055.

76: Xie W, Guo D, Li J, Yue L, Kang Q, Chen G, Zhou T, Wang H, Zhuang K, Leng L,
Li H, Chen Z, Gao W, Zhang J. CEND1 deficiency induces mitochondrial dysfunction
and cognitive impairment in Alzheimer's disease. Cell Death Differ. 2022 Jun 22.
doi: 10.1038/s41418-022-01027-7. Epub ahead of print. PMID: 35732922.

77: Zhang Y, Bai X, Zhang Y, Yao S, Cui Y, You LH, Yu P, Chang YZ, Gao G.
Hippocampal Iron Accumulation Impairs Synapses and Memory via Suppressing Furin
Expression and Downregulating BDNF Maturation. Mol Neurobiol. 2022
Sep;59(9):5574-5590. doi: 10.1007/s12035-022-02929-w. Epub 2022 Jun 23. PMID:
35732869.

78: Leem YH, Park JS, Park JE, Kim DY, Kim HS. Neurogenic effects of rotarod
walking exercise in subventricular zone, subgranular zone, and substantia nigra
in MPTP-induced Parkinson's disease mice. Sci Rep. 2022 Jun 22;12(1):10544. doi:
10.1038/s41598-022-14823-5. PMID: 35732806; PMCID: PMC9217938.

79: Yang S, Datta D, Elizabeth Woo, Duque A, Morozov YM, Arellano J, Slusher BS,
Wang M, Arnsten AFT. Inhibition of glutamate-carboxypeptidase-II in dorsolateral
prefrontal cortex: potential therapeutic target for neuroinflammatory cognitive
disorders. Mol Psychiatry. 2022 Jun 22. doi: 10.1038/s41380-022-01656-x. Epub
ahead of print. PMID: 35732693.

80: Lucaci AG, Notaras MJ, Kosakovsky Pond SL, Colak D. The evolution of BDNF is
defined by strict purifying selection and prodomain spatial coevolution, but
what does it mean for human brain disease? Transl Psychiatry. 2022 Jun
22;12(1):258. doi: 10.1038/s41398-022-02021-w. PMID: 35732627; PMCID:
PMC9217794.

81: Targa Dias Anastacio H, Matosin N, Ooi L. Neuronal hyperexcitability in
Alzheimer's disease: what are the drivers behind this aberrant phenotype? Transl
Psychiatry. 2022 Jun 22;12(1):257. doi: 10.1038/s41398-022-02024-7. PMID:
35732622; PMCID: PMC9217953.

82: Gottesman RF, Wu A, Coresh J, Knopman DS, Jack CR Jr, Rahmim A, Sharrett AR,
Spira AP, Wong DF, Wagenknecht LE, Hughes TM, Walker KA, Mosley TH. Associations
of Vascular Risk and Amyloid Burden with Subsequent Dementia. Ann Neurol. 2022
Oct;92(4):607-619. doi: 10.1002/ana.26447. Epub 2022 Aug 3. PMID: 35732594.

83: Lawton M, Tan MM, Ben-Shlomo Y, Baig F, Barber T, Klein JC, Evetts SG,
Millin S, Malek N, Grosset K, Barker RA, Williams N, Burn DJ, Foltynie T, Morris
HR, Wood N, Grosset DG, Hu MT. Genetics of validated Parkinson's disease
subtypes in the Oxford Discovery and Tracking Parkinson's cohorts. J Neurol
Neurosurg Psychiatry. 2022 Jun 22;93(9):952–9. doi: 10.1136/jnnp-2021-327376.
Epub ahead of print. PMID: 35732412; PMCID: PMC9380504.

84: Wang W, Lin X, Dong X, Sun Y. A multi-target theranostic nano-composite
against Alzheimer's disease fabricated by conjugating carbon dots and triple-
functionalized human serum albumin. Acta Biomater. 2022 Aug;148:298-309. doi:
10.1016/j.actbio.2022.06.029. Epub 2022 Jun 19. PMID: 35732234.

85: Zhao Y, Mahy W, Willis NJ, Woodward HL, Steadman D, Bayle ED, Atkinson BN,
Sipthorp J, Vecchia L, Ruza RR, Harlos K, Jeganathan F, Constantinou S, Costa A,
Kjær S, Bictash M, Salinas PC, Whiting P, Vincent JP, Fish PV, Jones EY.
Structural Analysis and Development of Notum Fragment Screening Hits. ACS Chem
Neurosci. 2022 Jul 6;13(13):2060-2077. doi: 10.1021/acschemneuro.2c00325. Epub
2022 Jun 22. PMID: 35731924; PMCID: PMC9264368.

86: Lirong W, Mingliang Z, Mengci L, Qihao G, Zhenxing R, Xiaojiao Z, Tianlu C.
The clinical and mechanistic roles of bile acids in depression, Alzheimer's
disease, and stroke. Proteomics. 2022 Aug;22(15-16):e2100324. doi:
10.1002/pmic.202100324. Epub 2022 Jul 13. PMID: 35731901.

87: Ingham DJ, Hillyer KM, McGuire MJ, Gamblin TC. <i>In vitro</i> Tau
Aggregation Inducer Molecules Influence the Effects of <i>MAPT</i> Mutations on
Aggregation Dynamics. Biochemistry. 2022 Jul 5;61(13):1243-1259. doi:
10.1021/acs.biochem.2c00111. Epub 2022 Jun 22. PMID: 35731895; PMCID:
PMC9260964.

88: McDowell C, Tamburri N, Smith AP, Dujela C, Sheets DJ, MacDonald SWS.
Exploring the impact of community-based choral participation on cognitive
function and well-being for persons with dementia: evidence from the Voices in
Motion project. Aging Ment Health. 2022 Jun 22:1-8. doi:
10.1080/13607863.2022.2084508. Epub ahead of print. PMID: 35731828.

89: Schinle M, Erler C, Kaliciak M, Milde C, Stock S, Gerdes M, Stork W. Digital
Health Apps in the Context of Dementia: Questionnaire Study to Assess the
Likelihood of Use Among Physicians. JMIR Form Res. 2022 Jun 22;6(6):e35961. doi:
10.2196/35961. PMID: 35731567; PMCID: PMC9260525.

90: Brück CC, Wolters FJ, Ikram MA, de Kok IMCM. Projected prevalence and
incidence of dementia accounting for secular trends and birth cohort effects: a
population-based microsimulation study. Eur J Epidemiol. 2022 Aug;37(8):807-814.
doi: 10.1007/s10654-022-00878-1. Epub 2022 Jun 22. PMID: 35731313; PMCID:
PMC9215138.

91: Sokolová M, Šestáková H, Truksa M, Šafařík M, Hadravová R, Bouř P, Šebestík
J. Photochemical synthesis of pink silver and its use for monitoring peptide
nitration via surface enhanced Raman spectroscopy (SERS). Amino Acids. 2022
Sep;54(9):1261-1274. doi: 10.1007/s00726-022-03178-w. Epub 2022 Jun 22. PMID:
35731286.

92: Ayati M, Yılmaz S, Chance MR, Koyuturk M. Functional Characterization of Co-
Phosphorylation Networks. Bioinformatics. 2022 Jun 22;38(15):3785–93. doi:
10.1093/bioinformatics/btac406. Epub ahead of print. PMID: 35731218; PMCID:
PMC9344848.

93: Lemke G, Huang Y. The dense-core plaques of Alzheimer's disease are
granulomas. J Exp Med. 2022 Aug 1;219(8):e20212477. doi: 10.1084/jem.20212477.
Epub 2022 Jun 22. PMID: 35731195; PMCID: PMC9225945.

94: Gerstenecker A, Martin RC, Hebert K, Triebel K, Marson DC. Cognitive
Correlates of Impaired Testamentary Capacity in Alzheimer's Dementia. Arch Clin
Neuropsychol. 2022 Aug 23;37(6):1148-1157. doi: 10.1093/arclin/acac034. PMID:
35731016.

95: Stites SD, Vogt NM, Blacker D, Rumbaugh M, Parker MW; Advisory Group on Risk
Evidence Education for Dementia (AGREED). Patients asking about APOE gene test
results? Here's what to tell them. J Fam Pract. 2022 May;71(4):E1-E7. doi:
10.12788/jfp.0397. PMID: 35730709.

96: Zam W, Quispe C, Sharifi-Rad J, López MD, Schoebitz M, Martorell M, Sharopov
F, Fokou PVT, Mishra AP, Chandran D, Kumar M, Chen JT, Pezzani R. An Updated
Review on The Properties of <i>Melissa officinalis</i> L.: Not Exclusively Anti-
anxiety. Front Biosci (Schol Ed). 2022 Jun 7;14(2):16. doi:
10.31083/j.fbs1402016. PMID: 35730441.

97: Xu X, Ruan X, Ju R, Wang Z, Yang Y, Cheng J, Gu M, Mueck AO. Progesterone
Receptor Membrane Component-1 May Promote Survival of Human Brain Microvascular
Endothelial Cells in Alzheimer's Disease. Am J Alzheimers Dis Other Demen. 2022
Jan-Dec;37:15333175221109749. doi: 10.1177/15333175221109749. PMID: 35730360.

98: Ryu WI, Shen M, Lee Y, Healy RA, Bormann MK, Cohen BM, Sonntag KC.
Nicotinamide riboside and caffeine partially restore diminished NAD availability
but not altered energy metabolism in Alzheimer's disease. Aging Cell. 2022
Jul;21(7):e13658. doi: 10.1111/acel.13658. Epub 2022 Jun 21. PMID: 35730144;
PMCID: PMC9282847.

99: Lin J, Gaudreault F, Johnson N, Lin Z, Nouri P, Goosen TC, Sawant-Basak A.
Investigation of CYP3A induction by PF-05251749 in early clinical development:
comparison of linear slope physiologically based pharmacokinetic prediction and
biomarker response. Clin Transl Sci. 2022 Sep;15(9):2184-2194. doi:
10.1111/cts.13352. Epub 2022 Jul 2. PMID: 35730131; PMCID: PMC9468555.

100: Lakhera S, Devlal K, Rana M, Celik I. Study of nonlinear optical responses
of phytochemicals of <i>Clitoria ternatea</i> by quantum mechanical approach and
investigation of their anti-Alzheimer activity with in silico approach. Struct
Chem. 2022 Jun 16:1-16. doi: 10.1007/s11224-022-01981-5. Epub ahead of print.
PMID: 35729937; PMCID: PMC9201267.

101: Matsubara T, Nakai M, Nishihara M, Miyamoto E, Sato T. Ganglioside
Nanocluster-Targeting Peptidyl Inhibitor Prevents Amyloid β Fibril Formation on
the Neuronal Membrane. ACS Chem Neurosci. 2022 Jul 6;13(13):1868-1876. doi:
10.1021/acschemneuro.2c00047. Epub 2022 Jun 21. PMID: 35729803.

102: Lu K, Wang Y, Zhang H, Tian C, Wang W, Yang T, Qi B, Wu S. Rational Design
of a Theranostic Agent Triggered by Endogenous Nitric Oxide in a Cellular Model
of Alzheimer's Disease. J Med Chem. 2022 Jul 14;65(13):9193-9205. doi:
10.1021/acs.jmedchem.2c00399. Epub 2022 Jun 21. PMID: 35729801.

103: Guo P, Gong W, Li Y, Liu L, Yan R, Wang Y, Zhang Y, Yuan Z. Pinpointing
novel risk loci for Lewy body dementia and the shared genetic etiology with
Alzheimer's disease and Parkinson's disease: a large-scale multi-trait
association analysis. BMC Med. 2022 Jun 22;20(1):214. doi:
10.1186/s12916-022-02404-2. PMID: 35729600; PMCID: PMC9214990.

104: Mohebichamkhorami F, Fattahi R, Niknam Z, Aliashrafi M, Khakpour Naeimi S,
Gilanchi S, Zali H. Periodontal ligament stem cells as a promising therapeutic
target for neural damage. Stem Cell Res Ther. 2022 Jun 21;13(1):273. doi:
10.1186/s13287-022-02942-9. PMID: 35729595; PMCID: PMC9210648.

105: He H, Zhou S, Peng C, Ran W, Tong S, Hong L, Cai F, Jin W, Jiang Y, Li M,
Wang X, Luo M, Wang W, Zhao K. Effects of resilience on impulsivity, cognition
and depression during protracted withdrawal among Chinese male methamphetamine
users. BMC Psychiatry. 2022 Jun 21;22(1):414. doi: 10.1186/s12888-022-04041-8.
PMID: 35729547; PMCID: PMC9215047.

106: Yang L, Feng S, Wu C, Yang L. Microglia-Mediated Aβ Propagation in
Alzheimer's Disease. Neurosci Bull. 2022 Jun 21. doi:
10.1007/s12264-022-00907-9. Epub ahead of print. PMID: 35729454.

107: Zheng M, Yan J, Hao W, Ren Y, Zhou M, Wang Y, Wang K. Worsening hearing was
associated with higher β-amyloid and tau burden in age-related hearing loss. Sci
Rep. 2022 Jun 21;12(1):10493. doi: 10.1038/s41598-022-14466-6. PMID: 35729211;
PMCID: PMC9212197.

108: Yang L, Ball A, Liu J, Jain T, Li YM, Akhter F, Zhu D, Wang J. Cyclic
microchip assay for measurement of hundreds of functional proteins in single
neurons. Nat Commun. 2022 Jun 21;13(1):3548. doi: 10.1038/s41467-022-31336-x.
PMID: 35729174; PMCID: PMC9213506.

109: Loureiro JC, Silva LFAL, Pais MV, Forlenza OV. Anti-amyloid agents for
treating incipient Alzheimer's disease: a new hope? Braz J Psychiatry. 2022 Aug
20;44(4):368-369. doi: 10.47626/1516-4446-2022-2503. PMID: 35729067; PMCID:
PMC9375665.

110: Kumar D, Md Ashraf G, Bilgrami AL, Imtaiyaz Hassan M. Emerging therapeutic
developments in neurodegenerative diseases: A clinical investigation. Drug
Discov Today. 2022 Oct;27(10):103305. doi: 10.1016/j.drudis.2022.06.005. Epub
2022 Jun 18. PMID: 35728774.

111: Yang TX, Zhu YF, Wang CC, Yang JY, Xue CH, Huang QR, Wang YM, Zhang TT.
EPA-enriched plasmalogen attenuates the cytotoxic effects of LPS-stimulated
microglia on the SH-SY5Y neuronal cell line. Brain Res Bull. 2022
Aug;186:143-152. doi: 10.1016/j.brainresbull.2022.06.002. Epub 2022 Jun 18.
PMID: 35728742.

112: Wu NS, Lin YF, Ma IC, Ko HJ, Hong YR. Many faces and functions of GSKIP: a
temporospatial regulation view. Cell Signal. 2022 Sep;97:110391. doi:
10.1016/j.cellsig.2022.110391. Epub 2022 Jun 18. PMID: 35728705.

113: Wang AW, Liu YM, Zhu MM, Ma RX. Isosteroidal alkaloids of Fritillaria
taipaiensis and their implication to Alzheimer's disease: Isolation, structural
elucidation and biological activity. Phytochemistry. 2022 Sep;201:113279. doi:
10.1016/j.phytochem.2022.113279. Epub 2022 Jun 18. PMID: 35728673.

114: Li Q, Xiong B, Wang Y, Lyu W, Xing S, Chen Y, Liao Q, He S, Feng F, Liu W,
Chen Y, Sun H. A highly effective and stable butyrylcholinesterase inhibitor
with multi-faceted neuroprotection and cognition improvement. Eur J Med Chem.
2022 Sep 5;239:114510. doi: 10.1016/j.ejmech.2022.114510. Epub 2022 Jun 7. PMID:
35728508.

115: Tazwar M, Evia AM, Tamhane AA, Ridwan AR, Leurgans SE, Bennett DA,
Schneider JA, Arfanakis K. Limbic-predominant age-related TDP-43 encephalopathy
neuropathological change (LATE-NC) is associated with lower R<sub>2</sub>
relaxation rate: an ex-vivo MRI and pathology investigation. Neurobiol Aging.
2022 Sep;117:128-138. doi: 10.1016/j.neurobiolaging.2022.05.009. Epub 2022 May
28. PMID: 35728463.

116: Liang Y, Lee DYW, Zhen S, Sun H, Zhu B, Liu J, Lei D, Lin CJ, Zhang S,
Jacques NA, Quinti L, Ran C, Wang C, Griciuc A, Choi SH, Dai RH, Efferth T,
Tanzi RE, Zhang C. Natural medicine HLXL targets multiple pathways of amyloid-
mediated neuroinflammation and immune response in treating alzheimer's disease.
Phytomedicine. 2022 Sep;104:154158. doi: 10.1016/j.phymed.2022.154158. Epub 2022
May 13. PMID: 35728383.

117: Kherchouche A, Ben-Ahmed O, Guillevin C, Tremblais B, Julian A, Fernandez-
Maloigne C, Guillevin R. Attention-guided neural network for early dementia
detection using MRS data. Comput Med Imaging Graph. 2022 Jul;99:102074. doi:
10.1016/j.compmedimag.2022.102074. Epub 2022 May 27. PMID: 35728368.

118: Peterson A, Gottesman RT, Miller EC, Tom SE. The association of vasomotor
symptoms during the menopausal transition and cognition in later life.
Menopause. 2022 Jul 1;29(7):832-839. doi: 10.1097/GME.0000000000001986. PMID:
35728018.

119: Taylor JL, Pritchard HAT, Walsh KR, Strangward P, White C, Hill-Eubanks D,
Alakrawi M, Hennig GW, Allan SM, Nelson MT, Greenstein AS. Functionally linked
potassium channel activity in cerebral endothelial and smooth muscle cells is
compromised in Alzheimer's disease. Proc Natl Acad Sci U S A. 2022 Jun
28;119(26):e2204581119. doi: 10.1073/pnas.2204581119. Epub 2022 Jun 21. PMID:
35727988; PMCID: PMC9245656.

120: Litvinenko IV, Lobzin VY. [A new paradigm for the development of
neurodegenerative diseases on the example of Alzheimer's disease and Parkinson's
disease.]. Adv Gerontol. 2022;35(2):263-273. Russian. PMID: 35727933.

121: Zamani J, Sadr A, Javadi AH. Classification of early-MCI patients from
healthy controls using evolutionary optimization of graph measures of resting-
state fMRI, for the Alzheimer's disease neuroimaging initiative. PLoS One. 2022
Jun 21;17(6):e0267608. doi: 10.1371/journal.pone.0267608. PMID: 35727837; PMCID:
PMC9212187.

122: Ouyang J, Zhao Q, Adeli E, Sullivan EV, Pfefferbaum A, Zaharchuk G, Pohl
KM. Self-Supervised Longitudinal Neighbourhood Embedding. Med Image Comput
Comput Assist Interv. 2021 Sep-Oct;12902:80-89. doi:
10.1007/978-3-030-87196-3_8. Epub 2021 Sep 21. PMID: 35727732; PMCID:
PMC9204645.

123: Pang CCC, Sørensen MH, Lee K, Luk KC, Trojanowski JQ, Lee VMY, Noble W,
Chang RCC. Investigating key factors underlying neurodegeneration linked to
alpha-synuclein spread. Neuropathol Appl Neurobiol. 2022 Oct;48(6):e12829. doi:
10.1111/nan.12829. Epub 2022 Jul 4. PMID: 35727707.

124: Khalifa M, Abdelsalam RM, Safar MM, Zaki HF. Phosphodiesterase (PDE) III
inhibitor, Cilostazol, improved memory impairment in aluminum chloride-treated
rats: modulation of cAMP/CREB pathway. Inflammopharmacology. 2022 Jun 21. doi:
10.1007/s10787-022-01010-1. Epub ahead of print. Erratum in:
Inflammopharmacology. 2022 Aug 29;: PMID: 35727381.

125: Manca R, Pardiñas AF, Venneri A; Alzheimer’s Disease Neuroimaging
Initiative. The neural signatures of psychoses in Alzheimer's disease: a
neuroimaging genetics approach. Eur Arch Psychiatry Clin Neurosci. 2022 Jun 21.
doi: 10.1007/s00406-022-01432-6. Epub ahead of print. PMID: 35727357.

126: Wingo TS, Gerasimov ES, Canon SM, Lah JJ, Levey AI, Wingo AP. Alzheimer's
disease genetic burden is associated with mid-life depression among persons with
normal cognition. Alzheimers Dement. 2022 Jun 21. doi: 10.1002/alz.12716. Epub
ahead of print. PMID: 35727298.

127: Rubin R. New Test to Help Diagnose Alzheimer Disease. JAMA. 2022 Jun
21;327(23):2281. doi: 10.1001/jama.2022.9847. PMID: 35727289.

128: Olah VJ, Goettemoeller AM, Rayaprolu S, Dammer EB, Seyfried NT, Rangaraju
S, Dimidschstein J, Rowan MJM. Biophysical K<sub>v</sub>3 channel alterations
dampen excitability of cortical PV interneurons and contribute to network
hyperexcitability in early Alzheimer's. Elife. 2022 Jun 21;11:e75316. doi:
10.7554/eLife.75316. PMID: 35727131; PMCID: PMC9278953.

129: Lee LJ, Kim Y, Shamburek R, Ross A, Yang L, Bevans MF. Caregiving stress
and burden associated with cardiometabolic risk in family caregivers of
individuals with cancer. Stress. 2022 Jan;25(1):258-266. doi:
10.1080/10253890.2022.2037548. PMID: 35727023; PMCID: PMC9380420.

130: Groot C, Holstege H, Ossenkoppele R. Do genetic factors contribute to sex-
specific differences in resilience to amyloid pathology? Brain. 2022 Jul
29;145(7):2239-2241. doi: 10.1093/brain/awac216. PMID: 35726881; PMCID:
PMC9337802.

131: Dost FS, Erken N, Ontan MS, Ates Bulut E, Kaya D, Kocyigit SE, Dokuzlar O,
Aydin AE, Isik AT. Muscle Strength Seems to be Related to The Functional Status
and Severity of Dementia in Older Adults with Alzheimer's Disease. Curr Aging
Sci. 2022 Jun 16. doi: 10.2174/1573411018666220616114641. Epub ahead of print.
PMID: 35726809.

132: Sacco S, Falquero S, Bouis C, Akkaya M, Gallard J, Pichot A, Radice G,
Bazin F, Montestruc F, Hiance-Delahaye A, Rebillat AS. Modified cued recall test
in the French population with Down syndrome: A retrospective medical records
analysis. J Intellect Disabil Res. 2022 Aug;66(8-9):690-703. doi:
10.1111/jir.12957. Epub 2022 Jun 21. PMID: 35726628.

133: Matteo CR, Paolo V, Nicoletta A, Luca M, Paola LF, Maria FL, Sara B,
Alfredo C. Vascular lesions and brain atrophy in Alzheimer's, vascular and mixed
dementia: an optimized 3T MRI protocol reveals distinctive radiological
profiles. Curr Alzheimer Res. 2022 Jun 20. doi:
10.2174/1567205019666220620112831. Epub ahead of print. PMID: 35726416.

134: Maria de Souza M, Ribeiro Cenci A, Faoro Teixeira K, Machado V, Garcia
Mendes Schuler MC, Elisa Gonçalves A, Paula Dalmagro A, André Cazarin C, Luiz
Gomes Ferreira L, Sena de Oliveira A, Defini Andricopulo A. DYRK1A inhibitors
and perspectives for the treatment of Alzheimer's disease. Curr Med Chem. 2022
Jun 20. doi: 10.2174/0929867329666220620162018. Epub ahead of print. PMID:
35726411.

135: Zhao N, Chen H, Zhang W, Yao J, Tu Q, Yu X, Sun X. Bidirectional influences
between seizures and dementia: A systematic review and meta-analysis. Int J
Geriatr Psychiatry. 2022 Jul;37(7). doi: 10.1002/gps.5723. PMID: 35726376.

136: Lindquist LA, Miller-Winder AP, Schierer A, Murawski A, Opsasnick L, Curtis
LM, Kim KY, Ramirez-Zohfeld V. Aspects of cognition that impact aging-in-place
and long-term care planning. J Am Geriatr Soc. 2022 Sep;70(9):2646-2652. doi:
10.1111/jgs.17927. Epub 2022 Jun 20. PMID: 35726136; PMCID: PMC9489627.

137: Jellinger KA. Morphological basis of Parkinson disease-associated cognitive
impairment: an update. J Neural Transm (Vienna). 2022 Aug;129(8):977-999. doi:
10.1007/s00702-022-02522-4. Epub 2022 Jun 20. PMID: 35726096.

138: Wightman DP, Jansen IE, Savage JE, Shadrin AA, Bahrami S, Holland D, Rongve
A, Børte S, Winsvold BS, Drange OK, Martinsen AE, Skogholt AH, Willer C, Bråthen
G, Bosnes I, Nielsen JB, Fritsche LG, Thomas LF, Pedersen LM, Gabrielsen ME,
Johnsen MB, Meisingset TW, Zhou W, Proitsi P, Hodges A, Dobson R, Velayudhan L,
Heilbron K, Auton A; 23andMe Research Team, Sealock JM, Davis LK, Pedersen NL,
Reynolds CA, Karlsson IK, Magnusson S, Stefansson H, Thordardottir S, Jonsson
PV, Snaedal J, Zettergren A, Skoog I, Kern S, Waern M, Zetterberg H, Blennow K,
Stordal E, Hveem K, Zwart JA, Athanasiu L, Selnes P, Saltvedt I, Sando SB,
Ulstein I, Djurovic S, Fladby T, Aarsland D, Selbæk G, Ripke S, Stefansson K,
Andreassen OA, Posthuma D. Author Correction: A genome-wide association study
with 1,126,563 individuals identifies new risk loci for Alzheimer's disease. Nat
Genet. 2022 Jul;54(7):1062. doi: 10.1038/s41588-022-01126-8. Erratum for: Nat
Genet. 2021 Sep;53(9):1276-1282. PMID: 35726068.

139: Bao YW, Shea YF, Chiu PK, Kwan JSK, Chan FH, Mak HK. Incremental diagnostic
value of 18F-Fluetemetamol PET in differential diagnoses of Alzheimer's Disease-
related neurodegenerative diseases from an unselected memory clinic cohort. Sci
Rep. 2022 Jun 20;12(1):10385. doi: 10.1038/s41598-022-14532-z. PMID: 35725910;
PMCID: PMC9209498.

140: Wood H. Restoring synapses in AD models. Nat Rev Neurol. 2022
Aug;18(8):453. doi: 10.1038/s41582-022-00691-0. PMID: 35725818.

141: Qiu S, Miller MI, Joshi PS, Lee JC, Xue C, Ni Y, Wang Y, De Anda-Duran I,
Hwang PH, Cramer JA, Dwyer BC, Hao H, Kaku MC, Kedar S, Lee PH, Mian AZ, Murman
DL, O'Shea S, Paul AB, Saint-Hilaire MH, Alton Sartor E, Saxena AR, Shih LC,
Small JE, Smith MJ, Swaminathan A, Takahashi CE, Taraschenko O, You H, Yuan J,
Zhou Y, Zhu S, Alosco ML, Mez J, Stein TD, Poston KL, Au R, Kolachalama VB.
Multimodal deep learning for Alzheimer's disease dementia assessment. Nat
Commun. 2022 Jun 20;13(1):3404. doi: 10.1038/s41467-022-31037-5. PMID: 35725739;
PMCID: PMC9209452.

142: Quintero-Villegas A, Valdés-Ferrer SI. Central nervous system effects of
5-HT<sub>7</sub> receptors: a potential target for neurodegenerative diseases.
Mol Med. 2022 Jun 20;28(1):70. doi: 10.1186/s10020-022-00497-2. PMID: 35725396;
PMCID: PMC9208181.

143: Dimachki S, Tarpin-Bernard F, Croisile B, Chainay H. Study design and
protocol of a low to high intensity computer-based cognitive training at home in
supplement to standard care in patients with AD. BMJ Open. 2022 Jun
20;12(6):e050993. doi: 10.1136/bmjopen-2021-050993. PMID: 35725247; PMCID:
PMC9214369.

144: Yeung MK, Chau AK, Chiu JY, Shek JT, Leung JP, Wong TC. Differential and
subtype-specific neuroimaging abnormalities in amnestic and nonamnestic mild
cognitive impairment: A systematic review and meta-analysis. Ageing Res Rev.
2022 Sep;80:101675. doi: 10.1016/j.arr.2022.101675. Epub 2022 Jun 17. PMID:
35724862.

145: Lv J, Xiao X, Bi M, Tang T, Kong D, Diao M, Jiao Q, Chen X, Yan C, Du X,
Jiang H. ATP-sensitive potassium channels: A double-edged sword in
neurodegenerative diseases. Ageing Res Rev. 2022 Sep;80:101676. doi:
10.1016/j.arr.2022.101676. Epub 2022 Jun 18. PMID: 35724860.

146: Lee S, Ryu SM, Kim DH, Lee YE, Lee SJ, Kang S, Kim JS, Lee SI.
Neuroprotective effect of Geijigadaehwang-tang against trimethyltin-induced
hippocampal neurodegeneration: An in vitro and in vivo study. J Ethnopharmacol.
2022 Oct 5;296:115451. doi: 10.1016/j.jep.2022.115451. Epub 2022 Jun 17. PMID:
35724744.

147: Giustiniani A, Danesin L, Bozzetto B, Macina A, Benavides-Varela S, Burgio
F. Functional changes in brain oscillations in dementia: a review. Rev Neurosci.
2022 Jun 21. doi: 10.1515/revneuro-2022-0010. Epub ahead of print. PMID:
35724724.

148: Mitok KA, Keller MP, Attie AD. Sorting through the extensive and confusing
roles of sortilin in metabolic disease. J Lipid Res. 2022 Aug;63(8):100243. doi:
10.1016/j.jlr.2022.100243. Epub 2022 Jun 18. PMID: 35724703; PMCID: PMC9356209.

149: G N S HS, Marise VLP, Rajalekshmi SG, Burri RR, Krishna Murthy TP.
Articulating target-mining techniques to disinter Alzheimer's specific targets
for drug repurposing. Comput Methods Programs Biomed. 2022 Jul;222:106931. doi:
10.1016/j.cmpb.2022.106931. Epub 2022 Jun 2. PMID: 35724476.

150: Li J, Zhao L, Ding X, Cui X, Qi L, Chen Y. Obstructive sleep apnea and the
risk of Alzheimer's disease and Parkinson disease: A Mendelian randomization
study OSA, Alzheimer's disease and Parkinson disease. Sleep Med. 2022
Sep;97:55-63. doi: 10.1016/j.sleep.2022.06.004. Epub 2022 Jun 9. PMID: 35724440.

151: Nafchi AR, Esmaeili M, Myers O, Oprea T, Bearer EL. Autophagy and
Herpesvirus: A collaboration Contributing to Alzheimer's Disease. FASEB J. 2022
May;36 Suppl 1. doi: 10.1096/fasebj.2022.36.S1.R2731. PMID: 35723876.

152: Hasnain N, Arif TB, Shafaut R, Zakaria F, Fatima SZ, Haque IU. Association
between sex and Huntington's disease: an updated review on symptomatology and
prognosis of neurodegenerative disorders. Wien Med Wochenschr. 2022 Jun 20.
English. doi: 10.1007/s10354-022-00941-2. Epub ahead of print. PMID: 35723821.

153: Amat-Ur-Rasool H, Ahmed M, Hasnain S, Ahmed A, Carter WG. In Silico Design
of Dual-Binding Site Anti-Cholinesterase Phytochemical Heterodimers as Treatment
Options for Alzheimer's Disease. Curr Issues Mol Biol. 2021 Dec
29;44(1):152-175. doi: 10.3390/cimb44010012. PMID: 35723391; PMCID: PMC8929005.

154: Nahalka J. Transcription of the Envelope Protein by 1-L Protein-RNA
Recognition Code Leads to Genes/Proteins That Are Relevant to the SARS-CoV-2
Life Cycle and Pathogenesis. Curr Issues Mol Biol. 2022 Feb 6;44(2):791-816.
doi: 10.3390/cimb44020055. PMID: 35723340; PMCID: PMC8928949.

155: Hussan MT, Matsui N, Matsui H. Evaluation of Ectopic Mitochondrial DNA in
HeLa Cells. Curr Issues Mol Biol. 2022 Mar 2;44(3):1215-1223. doi:
10.3390/cimb44030080. PMID: 35723303; PMCID: PMC8947175.

156: Dennison JL, Volmar CH, Modarresi F, Ke D, Wang J, Gravel E, Hammond-
Vignini S, Li Z, Timmons JA, Lohse I, Hayward MA, Brothers SP, Wahlestedt C.
Erratum to: JOTROL, a Novel Formulation of Resveratrol, Shows Beneficial Effects
in the 3xTg-AD Mouse Model. J Alzheimers Dis. 2022;88(1):385. doi:
10.3233/JAD-229006. Erratum for: J Alzheimers Dis. 2022;86(1):173-190. PMID:
35723129.

157: Sarto J, Mayà G, Molina-Porcel L, Balasa M, Gelpi E, Aldecoa I, Borrego-
Écija S, Contador J, Ximelis T, Vergara M, Antonell A, Sánchez-Valle R, Lladó A;
Neurological Tissue Bank, Biobanc-Hospital Clínic Barcelona-IDIBAPS
Collaborative Group. Evolution of Clinical-Pathological Correlations in Early-
Onset Alzheimer's Disease Over a 25-Year Period in an Academic Brain Bank. J
Alzheimers Dis. 2022;87(4):1659-1669. doi: 10.3233/JAD-220045. PMID: 35723108.

158: Tian J, Wang T, Jia K, Guo L, Swerdlow RH, Du H. Nonobese Male Patients
with Alzheimer's Disease Are Vulnerable to Decrease in Plasma Leptin. J
Alzheimers Dis. 2022;88(3):1017-1027. doi: 10.3233/JAD-220447. PMID: 35723107.

159: Bukhbinder AS, Ling Y, Hasan O, Jiang X, Kim Y, Phelps KN, Schmandt RE,
Amran A, Coburn R, Ramesh S, Xiao Q, Schulz PE. Risk of Alzheimer's Disease
Following Influenza Vaccination: A Claims-Based Cohort Study Using Propensity
Score Matching. J Alzheimers Dis. 2022;88(3):1061-1074. doi: 10.3233/JAD-220361.
PMID: 35723106; PMCID: PMC9484126.

160: Horvath A, Quinlan P, Eckerström C, Åberg ND, Wallin A, Svensson J. Low
Serum Insulin-like Growth Factor-I Is Associated with Decline in Hippocampal
Volume in Stable Mild Cognitive Impairment but not in Alzheimer's Disease. J
Alzheimers Dis. 2022;88(3):1007-1016. doi: 10.3233/JAD-220292. PMID: 35723105;
PMCID: PMC9484094.

161: Weissberger GH, Samek A, Mosqueda L, Nguyen AL, Lim AC, Fenton L, Han SD.
Increased Financial Altruism is Associated with Alzheimer's Disease
Neurocognitive Profile in Older Adults. J Alzheimers Dis. 2022;88(3):995-1005.
doi: 10.3233/JAD-220187. PMID: 35723104; PMCID: PMC9378573.

162: Mielke MM, Ransom JE, Mandrekar J, Turcano P, Savica R, Brown AW. Traumatic
Brain Injury and Risk of Alzheimer's Disease and Related Dementias in the
Population. J Alzheimers Dis. 2022;88(3):1049-1059. doi: 10.3233/JAD-220159.
PMID: 35723103; PMCID: PMC9378485.

163: Flicker L, Anstey KJ, Almeida OP, Waller M, Fitzgerald P, de Crespigny F,
Vu T, Dobson AJ. Differing Methodologies Are Required to Estimate Prevalence of
Dementia: Single Study Types Are No Longer Reliable. J Alzheimers Dis.
2022;88(3):943-948. doi: 10.3233/JAD-220093. PMID: 35723102.

164: Teichmann B, Gkioka M, Kruse A, Tsolaki M. Informal Caregivers' Attitude
Toward Dementia: The Impact of Dementia Knowledge, Confidence in Dementia Care,
and the Behavioral and Psychological Symptoms of the Person with Dementia. A
Cross-Sectional Study. J Alzheimers Dis. 2022;88(3):971-984. doi:
10.3233/JAD-215731. PMID: 35723101; PMCID: PMC9484115.

165: Kobayashi M, Yamada Y, Shinkawa K, Nemoto M, Nemoto K, Arai T. Automated
Early Detection of Alzheimer's Disease by Capturing Impairments in Multiple
Cognitive Domains with Multiple Drawing Tasks. J Alzheimers Dis.
2022;88(3):1075-1089. doi: 10.3233/JAD-215714. PMID: 35723100; PMCID:
PMC9484124.

166: Walter S, Kim AB, Flores M, Ziolkowski J, Shaffer E, Aggarwal NT. Including
General Audiences in a Virtual Scientific Dementia Conference: Will They Get
Anything From It? J Alzheimers Dis. 2022 Jun 13. doi: 10.3233/JAD-215681. Epub
ahead of print. PMID: 35723099.

167: Leonhardi J, Barthel H, Speerforck S, Dietzel J, Schroeter ML, Saur D,
Tiepolt S, Rullmann M, Patt M, Claßen J, Schomerus G, Sabri O. Differential
Diagnosis Between Alzheimer's Disease-Related Depression and Pseudo-Dementia in
Depression: A New Indication for Amyloid-β Imaging? J Alzheimers Dis.
2022;88(3):1029-1035. doi: 10.3233/JAD-215619. PMID: 35723098.

168: Lerner AJ. Biomarkers and Mindfulness: A Way Forward. J Alzheimers Dis.
2022 Jun 13. doi: 10.3233/JAD-215592. Epub ahead of print. PMID: 35723097.

169: Jester HM, Gosrani SP, Ding H, Zhou X, Ko MC, Ma T. Characterization of
Early Alzheimer's Disease-Like Pathological Alterations in Non-Human Primates
with Aging: A Pilot Study. J Alzheimers Dis. 2022;88(3):957-970. doi:
10.3233/JAD-215303. PMID: 35723096; PMCID: PMC9378582.

170: Zhu LY, Shi L, Luo Y, Leung J, Kwok T. Brain MRI Biomarkers to Predict
Cognitive Decline in Older People with Alzheimer's Disease. J Alzheimers Dis.
2022;88(2):763-769. doi: 10.3233/JAD-215189. PMID: 35723095.

171: Gan J, Liu S, Chen Z, Yang Y, Ma L, Meng Q, Wang XD, Liu C, Li X, Zhang W,
Ji Y. Elevated Plasma Orexin-A Levels in Prodromal Dementia with Lewy Bodies. J
Alzheimers Dis. 2022 Jun 14;88(3):1037-1048. doi: 10.3233/JAD-220082. PMID:
35723094.

172: Xue B, DasGupta D, Alam M, Khan MS, Wang S, Shamsi A, Islam A, Hassan MI.
Investigating binding mechanism of thymoquinone to human transferrin, targeting
Alzheimer's disease therapy. J Cell Biochem. 2022 Aug;123(8):1381-1393. doi:
10.1002/jcb.30299. Epub 2022 Jun 20. PMID: 35722728.

173: Rajani V, Yuan Q. Noradrenergic Modulation of the Piriform Cortex: A
Possible Avenue for Understanding Pre-Clinical Alzheimer's Disease Pathogenesis.
Front Cell Neurosci. 2022 May 26;16:908758. doi: 10.3389/fncel.2022.908758.
PMID: 35722616; PMCID: PMC9204642.

174: Velasco-Estevez M, Koch N, Klejbor I, Caratis F, Rutkowska A.
Mechanoreceptor Piezo1 Is Downregulated in Multiple Sclerosis Brain and Is
Involved in the Maturation and Migration of Oligodendrocytes <i>in vitro</i>.
Front Cell Neurosci. 2022 May 26;16:914985. doi: 10.3389/fncel.2022.914985.
PMID: 35722613; PMCID: PMC9204635.

175: Queiroz SAL, Ton AMM, Pereira TMC, Campagnaro BP, Martinelli L, Picos A,
Campos-Toimil M, Vasquez EC. The Gut Microbiota-Brain Axis: A New Frontier on
Neuropsychiatric Disorders. Front Psychiatry. 2022 Jun 1;13:872594. doi:
10.3389/fpsyt.2022.872594. PMID: 35722583; PMCID: PMC9198224.

176: Waterink L, Bakker ED, Visser LNC, Mangialasche F, Kivipelto M, Deckers K,
Köhler S, Sikkes SAM, Prins ND, Scheltens P, van der Flier WM, Zwan MD. Changes
in Brain-Health Related Modifiable Risk Factors in Older Adults After One Year
of COVID-19-Restrictions. Front Psychiatry. 2022 Jun 2;13:877460. doi:
10.3389/fpsyt.2022.877460. PMID: 35722572; PMCID: PMC9201112.

177: Khatoon R, Kaushik P, Parvez S. Mitochondria-Related Apoptosis Regulation
by Minocycline: A Study on a Transgenic <i>Drosophila</i> Model of Alzheimer's
Disease. ACS Omega. 2022 Jun 1;7(23):19106-19112. doi: 10.1021/acsomega.1c05653.
PMID: 35721948; PMCID: PMC9202010.

178: Fang M, Zhang Q, Wang X, Su K, Guan P, Hu X. Inhibition Mechanisms of
(-)-Epigallocatechin-3-gallate and Genistein on Amyloid-beta 42 Peptide of
Alzheimer's Disease via Molecular Simulations. ACS Omega. 2022 May
31;7(23):19665-19675. doi: 10.1021/acsomega.2c01412. PMID: 35721940; PMCID:
PMC9202277.

179: Bonci T, Salis F, Scott K, Alcock L, Becker C, Bertuletti S, Buckley E,
Caruso M, Cereatti A, Del Din S, Gazit E, Hansen C, Hausdorff JM, Maetzler W,
Palmerini L, Rochester L, Schwickert L, Sharrack B, Vogiatzis I, Mazzà C. An
Algorithm for Accurate Marker-Based Gait Event Detection in Healthy and
Pathological Populations During Complex Motor Tasks. Front Bioeng Biotechnol.
2022 Jun 2;10:868928. doi: 10.3389/fbioe.2022.868928. PMID: 35721859; PMCID:
PMC9201978.

180: Ooi H, Nasu R, Furukawa A, Takeuchi M, Koriyama Y. Pyridoxamine and
Aminoguanidine Attenuate the Abnormal Aggregation of β-Tubulin and Suppression
of Neurite Outgrowth by Glyceraldehyde-Derived Toxic Advanced Glycation End-
Products. Front Pharmacol. 2022 Jun 3;13:921611. doi: 10.3389/fphar.2022.921611.
PMID: 35721214; PMCID: PMC9204210.

181: Fasina OB, Wang J, Mo J, Osada H, Ohno H, Pan W, Xiang L, Qi J. Gastrodin
From <i>Gastrodia elata</i> Enhances Cognitive Function and Neuroprotection of
AD Mice <i>via</i> the Regulation of Gut Microbiota Composition and Inhibition
of Neuron Inflammation. Front Pharmacol. 2022 Jun 2;13:814271. doi:
10.3389/fphar.2022.814271. PMID: 35721206; PMCID: PMC9201506.

182: Alhusaini M, Eissa N, Saad AK, Beiram R, Sadek B. Revisiting Preclinical
Observations of Several Histamine H3 Receptor Antagonists/Inverse Agonists in
Cognitive Impairment, Anxiety, Depression, and Sleep-Wake Cycle Disorder. Front
Pharmacol. 2022 Jun 1;13:861094. doi: 10.3389/fphar.2022.861094. PMID: 35721194;
PMCID: PMC9198498.

183: Xu W, Jiang Y, Wang N, Bai H, Xu S, Xia T, Xin H. Traditional Chinese
Medicine as a Promising Strategy for the Treatment of Alzheimer's Disease
Complicated With Osteoporosis. Front Pharmacol. 2022 Jun 1;13:842101. doi:
10.3389/fphar.2022.842101. PMID: 35721142; PMCID: PMC9198449.

184: El-Darzi N, Mast N, Buchner DA, Saadane A, Dailey B, Trichonas G, Pikuleva
IA. Low-Dose Anti-HIV Drug Efavirenz Mitigates Retinal Vascular Lesions in a
Mouse Model of Alzheimer's Disease. Front Pharmacol. 2022 Jun 1;13:902254. doi:
10.3389/fphar.2022.902254. PMID: 35721135; PMCID: PMC9198296.

185: Kaliamoorthy S, Nagarajan M, Sethuraman V, Jayavel K, Lakshmanan V, Palla
S. Association of Alzheimer's disease and periodontitis - a systematic review
and meta-analysis of evidence from observational studies. Med Pharm Rep. 2022
Apr;95(2):144-151. doi: 10.15386/mpr-2278. Epub 2022 Apr 28. PMID: 35721037;
PMCID: PMC9176309.

186: Hong X, Huang K, Lin J, Ye X, Wu G, Chen L, Chen E, Zhao S. Combined Multi-
Atlas and Multi-Layer Perception for Alzheimer's Disease Classification. Front
Aging Neurosci. 2022 Jun 1;14:891433. doi: 10.3389/fnagi.2022.891433. PMID:
35721019; PMCID: PMC9199857.

187: Laczó M, Martinkovic L, Lerch O, Wiener JM, Kalinova J, Matuskova V,
Nedelska Z, Vyhnalek M, Hort J, Laczó J. Different Profiles of Spatial
Navigation Deficits In Alzheimer's Disease Biomarker-Positive Versus Biomarker-
Negative Older Adults With Amnestic Mild Cognitive Impairment. Front Aging
Neurosci. 2022 Jun 2;14:886778. doi: 10.3389/fnagi.2022.886778. PMID: 35721017;
PMCID: PMC9201637.

188: Lim BY, Lai KW, Haiskin K, Kulathilake KASH, Ong ZC, Hum YC, Dhanalakshmi
S, Wu X, Zuo X. Deep Learning Model for Prediction of Progressive Mild Cognitive
Impairment to Alzheimer's Disease Using Structural MRI. Front Aging Neurosci.
2022 Jun 2;14:876202. doi: 10.3389/fnagi.2022.876202. PMID: 35721012; PMCID:
PMC9201448.

189: Chen Z, Mo X, Chen R, Feng P, Li H. A Reparametrized CNN Model to
Distinguish Alzheimer's Disease Applying Multiple Morphological Metrics and Deep
Semantic Features From Structural MRI. Front Aging Neurosci. 2022 May
26;14:856391. doi: 10.3389/fnagi.2022.856391. PMID: 35721011; PMCID: PMC9204294.

190: Wu KY, Lin KJ, Chen CH, Liu CY, Wu YM, Chen CS, Yen TC, Hsiao IT. Decreased
Cerebral Amyloid-β Depositions in Patients With a Lifetime History of Major
Depression With Suspected Non-Alzheimer Pathophysiology. Front Aging Neurosci.
2022 May 26;14:857940. doi: 10.3389/fnagi.2022.857940. PMID: 35721010; PMCID:
PMC9204309.

191: Cao W, Lin J, Xiang W, Liu J, Wang B, Liao W, Jiang T. Physical Exercise-
Induced Astrocytic Neuroprotection and Cognitive Improvement Through Primary
Cilia and Mitogen-Activated Protein Kinases Pathway in Rats With Chronic
Cerebral Hypoperfusion. Front Aging Neurosci. 2022 Jun 1;14:866336. doi:
10.3389/fnagi.2022.866336. PMID: 35721009; PMCID: PMC9198634.

192: Russo T, Riessland M. Age-Related Midbrain Inflammation and Senescence in
Parkinson's Disease. Front Aging Neurosci. 2022 Jun 2;14:917797. doi:
10.3389/fnagi.2022.917797. PMID: 35721008; PMCID: PMC9204626.

193: Hilt S, Liu R, Maezawa I, Rojalin T, Aung HH, Budamagunta M, Slez R, Gong
Q, Carney RP, Voss JC. Novel Stilbene-Nitroxyl Hybrid Compounds Display Discrete
Modulation of Amyloid Beta Toxicity and Structure. Front Chem. 2022 May
26;10:896386. doi: 10.3389/fchem.2022.896386. PMID: 35720993; PMCID: PMC9204515.

194: Brinkley TE, Leng I, Register TC, Neth BJ, Zetterberg H, Blennow K, Craft
S. Changes in Adiposity and Cerebrospinal Fluid Biomarkers Following a Modified
Mediterranean Ketogenic Diet in Older Adults at Risk for Alzheimer's Disease.
Front Neurosci. 2022 Jun 2;16:906539. doi: 10.3389/fnins.2022.906539. PMID:
35720727; PMCID: PMC9202553.

195: Liu K, Li Q, Yao L, Guo X. The Coupled Representation of Hierarchical
Features for Mild Cognitive Impairment and Alzheimer's Disease Classification.
Front Neurosci. 2022 Jun 3;16:902528. doi: 10.3389/fnins.2022.902528. PMID:
35720713; PMCID: PMC9205193.

196: Bashit AA, Nepal P, Connors T, Oakley DH, Hyman BT, Yang L, Makowski L.
Mapping the Spatial Distribution of Fibrillar Polymorphs in Human Brain Tissue.
Front Neurosci. 2022 Jun 1;16:909542. doi: 10.3389/fnins.2022.909542. PMID:
35720706; PMCID: PMC9198601.

197: Hao L, Jia J, Xing Y, Han Y. <i>APOE</i> ε4 Allele Distribution and
Association With Scores of Subjective Cognitive Decline Questionnaire 9 in a
Large Chinese Memory Clinic Cohort. Front Neurosci. 2022 Jun 3;16:829031. doi:
10.3389/fnins.2022.829031. PMID: 35720695; PMCID: PMC9204235.

198: Pérez-González D, Schreiner TG, Llano DA, Malmierca MS. Alzheimer's
Disease, Hearing Loss, and Deviance Detection. Front Neurosci. 2022 Jun
2;16:879480. doi: 10.3389/fnins.2022.879480. PMID: 35720686; PMCID: PMC9201340.

199: Lopes KF, Bahia VS, Natividade JC, Bastos RVS, Shiguti WA, da Silva KER, de
Souza WC. Changes in personality traits in patients with Alzheimer's Disease.
Dement Neuropsychol. 2022 Apr-Jun;16(2):187-193. doi:
10.1590/1980-5764-DN-2021-0029. Epub 2022 Apr 29. PMID: 35720659; PMCID:
PMC9173796.

200: Mecê AM, Abreu VC, Lamas GM, Tacla RDR, Minekawa TB, Ramos CD, Balthazar
MLF. Lithium Intoxication as a cause of reversible dementia mimicking FDG PET
features of Alzheimer's disease. Dement Neuropsychol. 2022 Apr-
Jun;16(2):249-252. doi: 10.1590/1980-5764-DN-2021-0105. Epub 2022 Apr 29. PMID:
35720658; PMCID: PMC9173794.